Skip to main content
EFSA Journal logoLink to EFSA Journal
. 2021 Nov 19;19(11):e06907. doi: 10.2903/j.efsa.2021.6907

Safety and efficacy of a feed additive consisting of Bacillus subtilis strains CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 for all animal species (Nolivade)

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Vasileios Bampidis, Giovanna Azimonti, Maria de Lourdes Bastos, Henrik Christensen, Birgit Dusemund, Mojca Fašmon Durjava, Maryline Kouba, Marta López‐Alonso, Secundino López Puente, Francesca Marcon, Baltasar Mayo, Alena Pechová, Mariana Petkova, Fernando Ramos, Yolanda Sanz, Roberto Edoardo Villa, Ruud Woutersen, Maria Saarela, Jaume Galobart, Matteo Innocenti, Joana Revez, Maria Vittoria Vettori, Rosella Brozzi
PMCID: PMC8603003  PMID: 34824645

Abstract

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the preparation of Bacillus subtilis CNCM I‐4606, B. subtilis CNCM I‐5043, B. subtilis CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 when used as a technological additive (hygiene condition enhancer) for all animal species. The product is intended for use in compound feeds and feed materials for all animal species at a minimum inclusion level of 1 × 109 CFU B. subtilis and 1 × 109 CFU L. lactis per kg or litre. The two bacterial species are considered by EFSA to be eligible for the qualified presumption of safety (QPS) approach. As the identity of the strains has been clearly established and they did not show acquired resistance to antibiotics of human and veterinary importance, the use of these strains in animal nutrition is considered safe for the target species, consumers and the environment. The additive is not irritant to skin and eyes or a skin sensitiser. Given the proteinaceous nature of the active agents, the additive should be considered a respiratory sensitiser. The Panel is not in the position to conclude on the efficacy of the additive to significantly reduce the growth of either Salmonella Typhimurium or Escherichia coli in feed.

Keywords: technological additive, hygiene condition enhancer, Bacillus subtilis CNCM I‐4606, Bacillus subtilis CNCM I‐5043, Bacillus subtilis CNCM I‐4607, Lactococcus lactis CNCM I‐4609, efficacy

1. Introduction

1.1. Background and Terms of Reference

Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an application in accordance with Article 7.

The European Commission received a request from Nolivade2 for authorisation of a preparation of Bacillus subtilis CNCM I‐4606, Bacillus subtilis CNCM I‐5043, Bacillus subtilis CNCM I‐4607 and Lactococcus lactis CNCM I‐4609, when used as a feed additive for all animal species (category: technological additive; functional group: hygiene condition enhancers).

According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed additive or new use of a feed additive). EFSA received directly from the applicant the technical dossier in support of this application. The particulars and documents in support of the application were considered valid by EFSA as of 14 April 2020.

According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of the preparation of Bacillus subtilis CNCM I‐4606, Bacillus subtilis CNCM I‐5043, Bacillus subtilis CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 (MixBaLac), when used under the proposed conditions of use (see Section 3.1.4).

1.2. Additional information

This additive is a preparation containing viable spores of three strains of B. subtilis (CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607) and live cells of L. lactis (CNCM I‐4609). It has not been previously authorised as a feed or food additive in the European Union.

2. Data and methodologies

2.1. Data

The present assessment is based on data submitted by the applicant in the form of a technical dossier3 in support of the authorisation request for the use of a preparation of B. subtilis CNCM I‐4606, B. subtilis CNCM I‐5043, B. subtilis CNCM I‐4607 and L. lactis CNCM I‐4609 as a feed additive.

EFSA has verified the European Union Reference Laboratory (EURL) report as it relates to the methods used for the control of the active agent in animal feed. The Executive Summary of the EURL report can be found in Annex A.4

2.2. Methodologies

The approach followed by the FEEDAP Panel to assess the safety and the efficacy of a preparation of B. subtilis CNCM I‐4606, CNCM I‐5043, CNCM I‐4607 and L. lactis CNCM I‐4609 is in line with the principles laid down in Regulation (EC) No 429/20085 and the relevant guidance documents: Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012), Guidance on the identity, characterisation and conditions of use of feed additives (EFSA FEEDAP Panel, 2017a), Guidance on the assessment of the safety of feed additives for the target species (EFSA FEEDAP Panel, 2017b), Guidance on the assessment of the safety of feed additives for the consumer (EFSA FEEDAP Panel, 2017c), Guidance on the characterisation of microorganisms used as feed additives or as production organisms (EFSA FEEDAP Panel, 2018a), Guidance on the assessment of the efficacy of feed additives (EFSA FEEDAP Panel, 2018b) and Guidance on the assessment of the safety of feed additives for the environment (EFSA FEEDAP Panel, 2019).

3. Assessment

The present additive is based on a preparation containing viable spores of three strains of B. subtilis (CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607) and viable cells of L. lactis (CNCM I‐4609). It will be hereafter referred to as MixBaLac. MixBaLac is intended to be used as a technological additive (functional group: hygiene condition enhancers) in feed for all animal species to reduce the microbiological level of enteropathogens such as E. coli and Salmonella spp.6

3.1. Characterisation

3.1.1. Characterisation of the active agents

The four bacterial strains (three B. subtilis and one L. lactis strains) were originally isolated from the environment of poultry farms and are deposited in the Collection Nationale de Cultures de Microorganismes (CNCM) Institut Pasteur in France with the accession numbers CNCM I‐4606, CNCM I‐5043, CNCM I‐4607 and CNCM I‐4609, respectively.7 They have not been genetically modified.

The taxonomic identification of the strains as B. subtilis and L. lactis was confirmed based on the whole genome sequence (WGS). ■■■■■

The susceptibility of the bacterial strains to the battery of antibiotics recommended by the FEEDAP Panel (EFSA FEEDAP Panel, 2018a) was tested ■■■■■ for the strains B. subtilis CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607,12 ■■■■■ for L. lactis CNCM I‐4609.13 All the minimum inhibitory concentration (MIC) values were equal to or fell below the corresponding cut‐off values and, therefore, the strains are considered susceptible to the relevant antibiotics.

The ■■■■■ was used for mass screening of contigs for antimicrobial resistance genes using the ■■■■■ databases plus an in‐house database.14 ■■■■■ The screening did not identify any hits of concern for any of the bacterial strains.

Cytotoxicity of the supernatant obtained from the three B. subtilis strains was screened with Vero‐cells (LDH assay) according to the FEEDAP guidance (EFSA FEEDAP Panel, 2018a).15 No cytotoxic activity was detected.

3.1.2. Characterisation of the product

■■■■■ to reach a minimum declared content of 6.7 × 108 colony forming units (CFU)/g for each individual B. subtilis strain (2 × 109 CFU/g of all B. subtilis strains) (2–6%) and 2 × 109 CFU/g of L. lactis (1–8%). The applicant declared that no antimicrobials are used during the manufacturing of the additive.16

The specifications of active agents were confirmed by the analysis of five batches with a mean value of 8.4 × 109 CFU/g (range 6.6 × 109–1.1 × 1010 CFU/g) for all B. subtilis strains, and a mean value of 5.9 × 109 CFU/g (range 3.3 × 109–7 × 109 CFU/g) for the lactic acid bacterium.17 Enumeration of the individual B. subtilis strains was based ■■■■■.18 ■■■■■. Five batches showed a mean value of 1.5 × 109 CFU/g (range 9.2 × 108–2.9 × 109 CFU/g) for B. subtilis CNCM I‐4606, a mean value of 1.2 × 109 CFU/g (range 7.3 × 108–1.8 × 109 CFU/g) for B. subtilis CNCM I‐5043 and a mean value of 1.3 × 109 CFU/g (range 8.5 × 108–2.1 × 109 CFU/g) for B. subtilis CNCM I‐4607.

Microbial contaminants were analysed in three different batches.19 In all cases, the results were below the specifications (Enterobacteriaceae < 10 CFU/g, total coliforms < 10 CFU/g, E. coli < 10 CFU/g, Salmonella spp. no detection in 25 g, B. cereus < 100 CFU/g, coagulase‐positive staphylococci < 100 CFU/g, sulphite‐reducing anaerobes < 10 CFU/g, Clostridium perfringens < 10 CFU/g and yeasts and filamentous fungi < 103 CFU/g).

Three different batches of the additive were examined for the presence of arsenic, lead, cadmium, mercury, fluorine, dioxins, dioxins and dioxin‐like‐polychlorinated biphenyls (PCBs) and non‐dioxin‐like‐PCBs.20 Results showed mean values of 0.370 mg/kg for arsenic (range: 0.341–0.391 mg/kg), 1.298 mg/kg for lead (range: 1.140–1.448 mg/kg), 25.7 mg/kg for fluorine (range: 18.6–29.8 mg/kg), 0.027 ng/kg for dioxins (range: 0.024–0.031 ng/kg), 0.038 ng/kg for dioxins and dioxin‐like‐PCBs (range: 0.034–0.044 ng/kg) and 0.048 μg/kg for non‐dioxin‐like‐PCBs (range: 0.043–0.055 μg/kg); and levels below the limits of quantification (LOQs) for cadmium (<0.045 mg/kg) and mercury (< 0.023 mg/kg).

Three batches of MixBaLac were also analysed for mycotoxins concentration. The results showed the following mean values for deoxynivalenol (0.275 mg/kg, range: 0.265–0.295 mg/kg), zearalenone (0.12 mg/kg, range: 0.08–0.14 mg/kg), fumonisins B1 + B2 (0.25 mg/kg, range: 0.17–0.38 mg/kg) and T‐2+HT‐2 toxins (0.023 mg/kg, range: 0.01–0.035 mg/kg). Values for aflatoxin B1 and B2 and ochratoxin A were < LOQ.21 , 22

None of the above analysed impurities are considered of concern.

Three batches of the additive (carriers not specified) were examined for particle size distribution by laser diffraction and dusting potential by the Stauber–Heubach method.23 Results showed that 37% by volume of the additive consists of particles with diameters below 100 μm, 21% below 50 μm and 5% below 10 μm. The average dusting potential was 5.4 g/m3 (4.9–5.8 g/m3). The average bulk density and tapped density were 600 kg/m3 and 700 kg/m3, respectively.

3.1.3. Stability

The shelf‐life of MixBaLac was tested on three batches stored at –25°C, 5°C and 25°C/60% relative humidity (RH).24 Total bacilli and lactic acid bacteria counts after 6 months at –25°C and 3 months at 5°C showed no losses (< 0.5 Log). The applicant declared that the product did not prove to be stable at 25°C, and thus the results of these analyses were not provided. In a second study, the shelf‐life of the additive was tested on other three batches stored at –25°C for 12 months.25 No losses were observed (< 0.5 Log). Although no monitoring of individual strains of B. subtilis was done, in the absence of any significant reduction of total bacilli counts and based on the spore‐forming nature of the strains, these are expected to behave similarly.

The applicant states that MixBaLac is not intended to be used in commercial premixtures, but it could be used in specific premixtures based on mineral ingredients such as calcium carbonate, sepiolite and/or wheat feed to facilitate its incorporation in solid feedingstuffs. The stability of the additive (one batch) was tested when incorporated into a premixture containing ■■■■■, and a second premixture containing ■■■■■, and stored in heat‐sealed opaque bags at –25°C and 5°C and 25°C/60% RH.26 After 6 months no losses of Bacillus spp. counts were observed (< 0.5 Log units) in samples stored at –25°C and 5°C or of L. lactis counts (< 0.5 Log units) in samples stored at –25°C for both premixtures. The applicant declared a malfunctioning of the cooling chamber leading to unreliable results of L. lactis counts in samples stored at 5°C. Moreover, the applicant also declared that the additive proved not to be stable in these premixtures at 25°C/60% RH, and therefore, the results of the analysis were not submitted.

3.1.4. Conditions of use

The additive is intended for use in compound feeds and feed materials for all animal species at the minimum inclusion level of 1 × 109 total CFU B. subtilis and 1 × 109 CFU L. lactis per kg or litre.27

The applicant states that in case of dry feed, the additive is to be added to feed materials or compound feeds during the manufacturing process and/or when there is a risk of high moisture content and/or of contamination. In case of liquid feed, the additive should be added and mixed to dry feed just before the liquid preparation or directly in the liquid feed. MixBaLac is not intended to be used in commercial premixtures containing trace elements or preservatives.

3.2. Safety

3.2.1. Safety for the target species, consumers and environment

The species B. subtilis and L. lactis are considered by EFSA to be suitable for the Qualified Presumption of Safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2020). This approach requires the identification of the strains to be conclusively established and evidence that they do not show acquired resistance to antibiotics of human and veterinary importance, and in the case of the B. subtilis strains, these do not show toxigenic potential. In the view of the FEEDAP Panel the identity of the strains was unambiguously established as B. subtilis and L. lactis and the other applicable qualifications have been met. Consequently, B. subtilis CNCM I‐4606, B. subtilis CNCM I‐5043, B. subtilis CNCM I‐4607 and L. lactis CNCM I‐4609 are presumed safe for the target species, consumers and the environment. Since no risks are expected from other components of the additive, MixBaLac is also presumed to be safe for the target species, consumers and the environment.

3.2.2. Safety for the user

The potential of MixBaLac was tested in a valid in vitro study performed according to OECD guideline 439, which showed that it is not irritant to the skin.28

The eye irritation potential of MixBaLac was tested in a valid in vitro study performed according to OECD guideline 438, and no prediction could be made for eye irritation.29 Following the inconclusive results of the in vitro study and considering that MixBaLac is not skin irritant, an in vivo study was performed according to OECD guideline 405, which showed that the additive is not eye irritant/corrosive.30

A valid skin sensitisation in vivo study following OECD guideline 442B showed that MixBaLac does not have any skin sensitisation potential.31

The dusting potential (5.4 g/m3) suggests that exposure by inhalation is possible. Given the proteinaceous nature of the active agents, the additive should be considered a respiratory sensitiser.

The applicant listed several anticaking agents and carriers which would allow multiple formulations of the additive to be produced, and consequently, not all forms can be directly tested for user safety. However, for assessing the safety for the user of the additive, the active agents are the principal concern provided that other components do not introduce safety issues. For this specific product, the excipients used in the preparation of the final formulation do not introduce additional risks.

3.2.2.1. Conclusions on safety for the user

MixBaLac is not irritant to skin and eyes or a skin sensitiser but should be considered a respiratory sensitiser.

3.3. Efficacy

The additive is intended to improve the hygienic characteristics of the feed by reducing the microbiological level of enteropathogens such as E. coli and Salmonella spp. To support the efficacy as a hygiene condition enhancer, 13 in vitro studies were conducted. However, six32 of these were not further considered since the feed matrices used were sterilised prior to the inoculation of the additive and target organisms, and thus, these are considered not to represent the standard farming practices and conditions of use.

The remaining seven in vitro studies showed a common design and investigated the effects of MixBaLac in a range of feed matrices (Table 1). ■■■■■■■■■■■■■■■■■■■■■■■■■

Table 1.

Summary of the in vitro trials of different feed matrices inoculated with S. Typhimurium ■■■■■ or E. coli ■■■■■ and treated with MixBaLac

Study Feed matrix (% dry matter) inoculant Treatment MixBaLac (CFU Bacillus subtilis/l or kg and Lactococcus lactis/l or kg) Salmonella spp. or E. coli counts (log10 CFU/mL or g) at days of the experiment
0 1 2 3 5 7
1a ■■■■■ Control ■■■■■ ■■■■■
1 × 109
1 × 109 ■■■■■ ■■■■■
Δ ■■■■■ ■■■■■
2b ■■■■■ Control ■■■■■ ■■■■■ ■■■■■
1 × 109
1 × 109 ■■■■■ ■■■■■ ■■■■■
Δ ■■■■■ ■■■■■ ■■■■■
3c ■■■■■ Control ■■■■■ ■■■■■ ■■■■■
1 × 109
1 × 109 ■■■■■ ■■■■■ ■■■■■
Δ ■■■■■ ■■■■■ ■■■■■
4d ■■■■■ Control ■■■■■ ■■■■■ ■■■■■
1 × 109
1 × 109 ■■■■■ ■■■■■ ■■■■■
Δ ■■■■■ ■■■■■ ■■■■■
5e ■■■■■ Control ■■■■■ ■■■■■ ■■■■■
1 × 109
1 × 109 ■■■■■ ■■■■■ ■■■■■
Δ ■■■■■ ■■■■■ ■■■■■
6f ■■■■■ Control ■■■■■ ■■■■■ ■■■■■
1 × 109
1 × 109 ■■■■■ ■■■■■ ■■■■■
Δ ■■■■■ ■■■■■ ■■■■■
7g ■■■■■ Control ■■■■■ ■■■■■ ■■■■■
1 × 109
1 × 109 ■■■■■ ■■■■■ ■■■■■
Δ ■■■■■ ■■■■■ ■■■■■

CFU: colony forming unit.

a,b

Means in the same column within study are significantly different compared to control with p ≤ 0.05.

Δ: Salmonella spp. or E. coli counts (log10 CFU/mL) between control and MixBaLac; –: not measured.

a

Technical dossier/Section IV/Annex_IV_4_1 and Supplementary information April 2021/FAD‐2019‐0090_SIn_28.04.2021 and Annex_SIII_1 and Annex_SIII_8.

b

Technical dossier/Section IV/Annex_IV_5_1 and Supplementary information April 2021/FAD‐2019‐0090_SIn_28.04.2021 and Annex_SIII_2 and Annex_SIII_8.

c

Technical dossier/Section IV/Annex_SII_2 and Supplementary information April 2021/FAD‐2019‐0090_SIn_28.04.2021 and Annex_SIII_3, Annex_SIII_8 and Annex_SIII_9.

d

Technical dossier/Section IV/Annex_SII_3 and Supplementary information April 2021/FAD‐2019‐0090_SIn_28.04.2021/Annex_SIII_4, Annex_SIII_8 and Annex_SIII_9.

e

Technical dossier/Section IV/Annex_SII_4 and Supplementary information April 2021/FAD‐2019‐0090_SIn_28.04.2021/Annex_SIII_5, Annex_SIII_8 and Annex_SIII_9.

f

Technical dossier/Section IV/Annex_SII_5 and Supplementary information April 2021/FAD‐2019‐0090_SIn_28.04.2021/Annex_SIII_6, Annex_SIII_8 and Annex_SIII_9.

g

Technical dossier/Section IV/Annex_SII_6 and Supplementary information April 2021/FAD‐2019‐0090_SIn_28.04.2021/Annex_SIII_7, Annex_SIII_8 and Annex_SIII_9.

In study 1 with dry feed, no statistically significant differences were observed in Salmonella spp. counts between the treated soya meal and the control after 2 days of storage.

In study 2, treatment of a high moisture soya meal with the additive resulted in a statistically and biologically significant/relevant reduction of Salmonella spp. counts compared to control after 7 days of storage. While Salmonella spp. counts slightly increased in the control feed over time, these remained stable in the treated feed.

In study 3, treatment of a maize kernels with the additive resulted in a statistically and biologically significant/relevant reduction of Salmonella spp. counts compared to control after 3 days of storage; however, this difference was not maintained at the end of the experiment (5 days) as Salmonella spp. counts declined in both the control and the treated feed.

In studies 4 and 5, treatment of mash feed for ducks resulted in limited but statistically significant lower counts of Salmonella spp. and E. coli, respectively compared to control at all the timepoints monitored.

In the two studies with liquid feeds (6 and 7), a statistically and biologically significant/relevant reduction of Salmonella spp. counts in treated feeds compared to control was observed in all timepoints monitored.

The Panel notes that the marginal reduction of counts observed in studies 4 and 5 (< 1 log) leads to results of questionable biological/practical value. Moreover, the timepoints at which significant results were observed in studies 2 and 7 may be questionable from the practical viewpoint, which might limit the extrapolation of the results to practical use conditions. In addition, the Panel notes that the additive has been tested against only one strain of S. Typhimurium. Thus, no conclusions can be drawn on the efficacy of the additive against a diversity of Salmonella enterica in feeds.

3.3.1. Conclusions on efficacy

In two studies, the addition of MixBaLac showed the potential to limit the growth of Salmonella Typhimurium in feed with a dry matter (DM) range of 13–23%. In other two studies, the addition of MixBaLac showed the potential to maintain or decrease the growth of S. Typhimurium in feed with a DM range of 49–58% compared to the control. In a fifth study, the addition of MixBaLac showed the potential to decrease S. Typhimurium counts, but the persistence of the effect observed was not maintained over time.

The marginal reduction of counts observed between treatment groups in one study is questionable from the biological/practical viewpoint and the Panel has reservations on the relevance of the effects observed in other two studies under practical use conditions. Therefore, the Panel is not in the position to conclude on the efficacy of MixBaLac to significantly reduce the growth of S. Typhimurium in feed.

In the absence of three positive studies showing significant and biologically relevant results, the Panel is not in the position to conclude on the efficacy of MixBaLac to significantly reduce the growth of E. coli in feed.

4. Conclusions

The additive consisting of B. subtilis strains CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607 and L. lactis CNCM I‐4609 is considered safe for the target species, consumers and the environment.

The additive is not irritant to skin and eyes and is not a skin sensitiser but should be considered a respiratory sensitiser.

The Panel is not in the position to conclude on the efficacy of the additive to significantly reduce the growth of S. Typhimurium or E. coli in feed.

5. Documentation as provided to EFSA/Chronology

Date Event
18/12/2019 Dossier received by EFSA. MixBaLac (Bacillus subtilis CNCM I‐4606, CNCM I‐5043, CNCM I‐4607 and Lactococcus lactis CNCM I‐4609) as a hygiene condition enhancer for all animal species. Submitted by Nolivade.
22/01/2020 Reception mandate from the European Commission
14/04/2020 Application validated by EFSA – Start of the scientific assessment
01/07/2020 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 – Scientific assessment suspended. Issues: Characterisation of the additive
17/07/2020 Reception of the Evaluation report of the European Union Reference Laboratory for Feed Additives
22/09/2020 Reception of supplementary information from the applicant ‐ Scientific assessment re‐started
14/10/2020 Comments received from Member States
27/10/2020 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 – Scientific assessment suspended. Issues: efficacy
10/03/2021 Reception of supplementary information from the applicant ‐ Scientific assessment re‐started
28/04/2021 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 – Scientific assessment suspended. Issues: efficacy
26/05/2021 Reception of supplementary information from the applicant ‐ Scientific assessment re‐started
30/09/2021 Opinion adopted by the FEEDAP Panel. End of the Scientific assessment

Abbreviations

ANI

average nucleotide identity

CFU

colony forming unit

CLSI

Clinical and Laboratory Standards Institute

CV

coefficient of variation

DM

dry matter

EURL

European Union Reference Laboratory

FEEDAP

EFSA Panel on Additives and Products or Substances used in Animal Feed

MIC

minimum inhibitory concentration

OECD

Organisation for Economic Co‐operation and Development

PCB

polychlorinated biphenyl

qPCR

quantitative real‐time PCR

QPS

Qualified Presumption of Safety

RH

relative humidity

WGS

whole genome sequence

Annex A – Executive Summary of the Evaluation Report of the European Union Reference Laboratory for Feed Additives on the Method(s) of Analysis for MixBaLac

1.

In the current application an authorisation is sought under Article 4(1) for the preparation of Bacillus subtilis CNCM I‐4606, Bacillus subtilis CNCM I‐5043, Bacillus subtilis CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 (MixBaLac) under the category/functional group 1(n) ‘technological feed additive’/‘hygiene condition enhancer’, according to Annex I of Regulation (EC) No 1831/2003. The authorisation is sought for the use of the feed additive for all animal species.

According to the Applicant, the feed additive contains as an active substance the viable spores of Bacillus subtilis (CNCM I‐4606, CNCM I‐5043, CNCM I‐4607) and live cells of Lactococcus lactis (CNCM I‐4609). The feed additive contains a minimum content of 2 × 109 Colony Forming Units (CFU) of total Bacillus subtilis/g feed additive and a minimum content of 2 × 109 CFU of Lactococcus lactis/g feed additive.

The feed additive is intended to be used directly into feedingstuffs or through premixtures at a minimum dose of 1 × 109 CFU of total Bacillus subtilis/kg (or L) complete feedingstuffs and at a minimum dose of 1 × 109 CFU of Lactococcus lactis/kg (or L) complete feedingstuffs.

For the identification of Bacillus subtilis CNCM I‐4606, Bacillus subtilis CNCM I‐5043, Bacillus subtilis CNCM I‐4607 and Lactococcus lactis CNCM I‐4609, the EURL recommends for official control Pulsed Field Gel Electrophoresis (PFGE), a generally recognised methodology for genetic identification of bacterial strains.

For the enumeration of the total Bacillus subtilis (CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607) in the feed additive, premixtures and feedingstuffs the Applicant submitted the ring‐trial validated spread‐plate CEN method EN 15784.

Based on the performance characteristics available, the EURL recommends this method for official control for the enumeration of the total Bacillus subtilis (CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607) in the feed additive, premixtures and feedingstuffs.

For the enumeration of Lactococcus lactis (CNCM I‐4609) in the feed additive, premixtures and feedingstuffs the Applicant proposed the ISO 15214 pour‐plate method dedicated for the enumeration of mesophilic lactic acid bacteria in food and feed.

Based on acceptable applicability data of the method, the EURL recommends it for official control for the enumeration of Lactococcus lactis (CNCM I‐4609) in the feed additive, premixtures and feedingstuffs.

Further testing or validation of the methods to be performed through the consortium of National Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005, as last amended by Regulation (EU) 2015/1761) is not considered necessary.

Suggested citation: EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed) , Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fašmon Durjava M, Kouba M, López‐Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Saarela M, Galobart J, Innocenti M, Revez J, Vettori MV and Brozzi R, 2021. Scientific Opinion on the safety and efficacy of a feed additive consisting of Bacillus subtilis strains CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 for all animal species (Nolivade). EFSA Journal 2021;19(11):6907, 12 pp. 10.2903/j.efsa.2021.6907

Requestor: European Commission

Question number: EFSA‐Q‐2020‐00202

Panel members: Giovanna Azimonti, Vasileios Bampidis, Maria de Lourdes Bastos, Henrik Christensen, Birgit Dusemund, Maryline Kouba, Mojca Kos Durjava, Marta López‐Alonso, Secundino López Puente, Francesca Marcon, Baltasar Mayo, Alena Pechová, Mariana Petkova, Fernando Ramos, Yolanda Sanz, Roberto Edoardo Villa and Ruud Woutersen.

Legal notice: Relevant information or parts of this scientific output have been blackened in accordance with the confidentiality requests formulated by the applicant pending a decision thereon by the European Commission. The full output has been shared with the European Commission, EU Member States and the applicant. The blackening will be subject to review once the decision on the confidentiality requests is adopted by the European Commission.

Declarations of interest: The declarations of interest of all scientific experts active in EFSA's work are available at https://ess.efsa.europa.eu/doi/doiweb/doisearch.

Acknowledgements: The Panel wishes to acknowledge the contribution of Yolanda García Cazorla to this opinion.

Adopted: 30 September 2021

Notes

1

Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition. OJ L 268, 18.10.2003, p. 29.

2

Nolivade, 2/4 avenue de Ker Lann CS 17228, 35172, BRUZ Cedex, France.

3

FEED dossier reference: FAD‐2019‐0090.

4

The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/default/files/finrep-fad-2019-0090-mixbalac.pdf

5

Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.

6

Technical dossier/Supplementary information February 2021/FAD‐2019‐0090_SIn_27.10.20.

7

Technical dossier/Section II/Annex_II_2_10.

8

Technical dossier/Section II/Annex II_2.1.

9

Technical dossier/Section II/Annex II_2.2.

10

Technical dossier/Section II/Annex II_2.3.

11

Technical dossier/Section II/Annex II_2.7.

12

Technical dossier/Section II/Annex II_2.20.

13

Technical dossier/Section II/Annex II_2.21.

14

Technical dossier/Annexes II_2_1, II_2_2 and II_2_3.

15

Technical dossier/Section II/Annex II_2_24.

16

Technical dossier/Section II.

17

Technical dossier/Section II/Annex_II_1_4 and Annex II_1_6.

18

Technical dossier/Supplementary information September 2020/FAD‐2019‐0090_SIn_01.07.20/Annex SI_2 and Annex SI_3.

19

Technical dossier/Section II/Annex_II_1_9.

20

Technical dossier/Section II/Annex_II_1_8.

21

Technical dossier/Section II/Annex_II_1_10.

22

Limits of quantification: T‐2 + HT‐2 toxins: 0.01 mg/kg, deoxynivalenol: 0.01 mg/kg, zearalenone: 0.01, fumonisins B1 + B2: 0.01 mg/kg, aflatoxin B1 and B2: 0.001 mg/kg and ochratoxin A: 0.001 mg/kg.

23

Technical dossier/Section II/Annex_II_1_11.

24

Technical dossier/Section II/Annex_II_4_1 and Annex_II_1_4.

25

Technical dossier/Supplementary information September 2020/FAD‐2019‐0090_SIn_01.07.20/Annex SIn 4.

26

Technical dossier/Supplementary information July 2020/Annex_II_4_2.

27

Technical dossier/Supplementary information February 2021.

28

Technical dossier/Section III/Annex_III_3.1.

29

Technical dossier/Section III/Annex_III_3.2.

30

Technical dossier/section III/Annex_III_3.3.

31

Technical dossier/Section III/Annex_III_3.4.

32

Technical dossier/Section IV/Annex_IV_2_1, Annex IV.2.2, Annex IV.2.3, Annex_IV_2_4, Annex_IV_2_5 and Annex_IV_3_1.

33

From the Institut Pasteur culture collection.

34

From NOLIVADE culture collection ■■■■■.

References

  1. EFSA (European Food Safety Authority), 2007. Opinion of the Scientific Committee on a request from EFSA on the introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. EFSA Journal 2007;587, 16 pp. 10.2903/j.efsa.2007.587 [DOI] [Google Scholar]
  2. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), Koutsoumanis K, Allende A, Alvarez‐Ordóñez A, Bolton D, Bover‐Cid S, Chemaly M, Davies R, De Cesare A, Hilbert F, Lindqvist R, Nauta M, Peixe L, Ru G, Simmons M, Skandamis P, Suffredini E, Cocconcelli PS, Fernández Escámez PS, Maradona MP, Querol A, Suarez JE, Sundh I, Vlak J, Barizzone F, Correia S and Herman L, 2020. Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA (2017–2019). EFSA Journal 2020;18(2):5966, 56 pp. 10.2903/j.efsa.2020.5966 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 2012. Guidance on studies concerning the safety of use of the additive for users/workers. EFSA Journal 2012;10(1):2539, 5 pp. 10.2903/j.efsa.2012.2539 [DOI] [Google Scholar]
  4. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Villa RE, Wallace RJ, Wester P, Anguita M, Galobart J and Innocenti ML, 2017a. Guidance on the identity, characterisation and conditions of use of feed additives. EFSA Journal 2017;15(10):5023, 12 pp. 10.2903/j.efsa.2017.5023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Villa RE, Wallace RJ, Wester P, Anguita M, Galobart J, Innocenti ML and Martino L, 2017b. Guidance on the assessment of the safety of feed additives for the target species. EFSA Journal 2017;15(10):5021, 19 pp. 10.2903/j.efsa.2017.5021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Villa RE, Wallace RJ, Wester P, Anguita M, Dujardin B, Galobart J and Innocenti ML, 2017c. Guidance on the assessment of the safety of feed additives for the consumer. EFSA Journal 2017;15(10):5022, 17 pp. 10.2903/j.efsa.2017.5022 [DOI] [Google Scholar]
  7. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Villa RE, Wallace RJ, Wester P, Glandorf B, Herman L, Kärenlampi S, Aguilera J, Anguita M, Brozzi R and Galobart J, 2018a. Guidance on the characterisation of microorganisms used as feed additives or as production organisms. EFSA Journal 2018;16(3):5206, 24 pp. 10.2903/j.efsa.2018.5206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Rychen G, Aquilina G, Azimonti G, Bampidis V, Bastos ML, Bories G, Chesson A, Cocconcelli PS, Flachowsky G, Gropp J, Kolar B, Kouba M, López‐Alonso M, López Puente S, Mantovani A, Mayo B, Ramos F, Saarela M, Villa RE, Wallace RJ, Wester P, Anguita M, Galobart J, Innocenti ML and Martino L, 2018b. Guidance on the assessment of the efficacy of feed additives. EFSA Journal 2018;16(5):5274, 25 pp. 10.2903/j.efsa.2018.5274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Bampidis V, Bastos ML, Christensen H, Dusemund B, Kouba M, Kos Durjava M, López‐Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Brock T, Knecht J, Kolar B, Beelen P, Padovani L, Tarrés‐Call J, Vettori MV and Azimonti G, 2019. Guidance on the assessment of the safety of feed additives for the environment. EFSA Journal 2019;17(4):5648, 78 pp. 10.2903/j.efsa.2019.5648 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from EFSA Journal are provided here courtesy of Wiley

RESOURCES